Asymmetric Hydrogenation vs. Resolution in the Synthesis of POSICOR®, a New Type of Calcium Antagonist
Author(s) -
Yvo Crameri,
Joseph Foricher,
Urs Hengartner,
Christian-Johannes Jenny,
Frank Kienzle,
Henri Ramuz,
Michelangelo Scalone,
Markus G. Schlageter,
Rudolf Schmid,
Shaoning Wang
Publication year - 1997
Publication title -
chimia international journal for chemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.387
H-Index - 55
eISSN - 2673-2424
pISSN - 0009-4293
DOI - 10.2533/chimia.1997.303
Subject(s) - mibefradil , asymmetric hydrogenation , chemistry , antagonist , catalysis , cascade , calcium , combinatorial chemistry , resolution (logic) , optically active , enantioselective synthesis , organic chemistry , chromatography , computer science , receptor , voltage dependent calcium channel , biochemistry , artificial intelligence
The pilot-plant-scale synthesis of (S)-2-(4-fluorophenyl)-3-methylbutanoic acid by asymmetric hydrogenation of 2-(4-fluorophenyl)-3-methylbut-2-enoic acid with the [Ru((R)-MeOBIPHEP)(OAc)2]-catalyst is described. The hydrogenation was performed in a continuous mode in a cascade stirred-tank reactor system at 270 bar pressure. The (S)-2-(4-fluorophenyl)-3-methylbutanoic acid is an important optically active intermediate in the synthesis of mibefradil, a new type of calcium antagonist.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom